Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis.
JCV-negative natalizumab-associated progressive multifocal leukoencephalopathy: a clinico-radiological diagnosis.
7 tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.
Phosphodiesterases in neurodegenerative disorders.
U.S. Postlicensure safety surveillance for adolescent and adult tetanus, diphtheria and acellular pertussis vaccines: 2005-2007.
Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis.
Biosynthetic Assembly of the Bacteroides fragilis Capsular Polysaccharide A Precursor Bactoprenyl Diphosphate-Linked Acetamido-4-amino-6-deoxygalactopyranose.
Multiple sclerosis: Linking disability and spinal cord imaging outcomes in MS.
Platelets and neurovascular inflammation.
Up-Regulation of Excitatory Amino Acid Transporters EAAT1 and EAAT2 by ß-Klotho.
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation.
High-mobility group box 1 up-regulates aquaporin 4 expression via microglia-astrocyte interaction.
So many progenitors, so little myelin.
Walking capacity and ability are more impaired in progressive compared to relapsing type of multiple sclerosis.
Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon-beta 1a: Case Report.
Prediction of antibody persistency from antibody titres to natalizumab.
From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitors.
Clinical Importance of Steps Taken per Day among Persons with Multiple Sclerosis.
Comparison of Magnetic Susceptibility Tensor and Diffusion Tensor of the Brain.
Evaluation of retinal nerve fiber layer thickness measured by optical coherence tomography in Moroccan patients with multiple sclerosis.
Targeting CXCL13 During Neuroinflammation.
Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis.
Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program.
Unemployment among women with multiple sclerosis: the role of coping and perceived stress and support in the workplace.
Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease.

Pages